Hospital Wastes as Potential Sources for Multi-Drug-Resistant ESBL-Producing Bacteria at a Tertiary Hospital in Ethiopia
- PMID: 38667050
- PMCID: PMC11047370
- DOI: 10.3390/antibiotics13040374
Hospital Wastes as Potential Sources for Multi-Drug-Resistant ESBL-Producing Bacteria at a Tertiary Hospital in Ethiopia
Abstract
The hospital environment is increasingly becoming an important reservoir for multi-drug-resistant (MDR) Gram-negative bacteria, posing serious challenges to efforts to combat antimicrobial resistance (AMR). This study aimed to investigate the role of hospital waste as a potential source of MDR ESBL-producing bacteria. Samples were collected from multiple sources within a hospital and its vicinity, including surface swabs, houseflies, and sewage samples. The samples were subsequently processed in a microbiology laboratory to identify potential pathogenic bacteria and confirmed using MALDI-TOF MS. Bacteria were isolated from 87% of samples, with the predominant isolates being E. coli (30.5%), Klebsiella spp. (12.4%), Providencia spp. (12.4%), and Proteus spp. (11.9%). According to the double disc synergy test (DDST) analysis, nearly half (49.2%) of the bacteria were identified as ESBL producers. However, despite exhibiting complete resistance to beta-lactam antibiotics, 11.8% of them did not test positive for ESBL production. The characterization of E. coli revealed that 30.6% and 5.6% of them carried blaCTX-M group 1 type-15 and blaNDM genes, respectively. This finding emphasizes the importance of proper hospital sanitation and waste management practices to mitigate the spread of AMR within the healthcare setting and safeguard the health of both patients and the wider community.
Keywords: CTX-M; ESBL; Gram-negative bacteria; MDR; NDM; hospital waste.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
A high prevalence of multi-drug resistant Gram-negative bacilli in a Nepali tertiary care hospital and associated widespread distribution of Extended-Spectrum Beta-Lactamase (ESBL) and carbapenemase-encoding genes.Ann Clin Microbiol Antimicrob. 2020 Oct 21;19(1):48. doi: 10.1186/s12941-020-00390-y. Ann Clin Microbiol Antimicrob. 2020. PMID: 33087115 Free PMC article.
-
Extended Spectrum Beta Lactamase (ESBL), blaTEM,blaSHV and blaCTX-M, Resistance Genes in Community and Healthcare Associated Gram Negative Bacteria from Osun State, Nigeria.Infect Disord Drug Targets. 2021;21(4):595-602. doi: 10.2174/1871526520999200729181559. Infect Disord Drug Targets. 2021. PMID: 32729432
-
Multidrug resistance and extended-spectrum beta-lactamase producing Gram-negative bacteria from three Referral Hospitals of Amhara region, Ethiopia.Ann Clin Microbiol Antimicrob. 2021 Mar 11;20(1):16. doi: 10.1186/s12941-021-00422-1. Ann Clin Microbiol Antimicrob. 2021. PMID: 33706775 Free PMC article.
-
Prevalence of CTX-M β-Lactamases Producing Multidrug Resistant Escherichia coli and Klebsiella pneumoniae among Patients Attending Bir Hospital, Nepal.Biomed Res Int. 2021 Jun 8;2021:9958294. doi: 10.1155/2021/9958294. eCollection 2021. Biomed Res Int. 2021. PMID: 34212045 Free PMC article.
-
High rate of extended-spectrum beta-lactamase-producing gram-negative infections and associated mortality in Ethiopia: a systematic review and meta-analysis.Antimicrob Resist Infect Control. 2020 Aug 8;9(1):128. doi: 10.1186/s13756-020-00782-x. Antimicrob Resist Infect Control. 2020. PMID: 32771059 Free PMC article.
Cited by
-
Prevalence of phenotypic drug resistance profiles and multi-drug-resistant Pseudomonas and Acinetobacter species recovered from clinical specimens in Ethiopia: a systematic review and meta-analysis.BMC Infect Dis. 2025 May 23;25(1):737. doi: 10.1186/s12879-025-11136-6. BMC Infect Dis. 2025. PMID: 40410730 Free PMC article.
-
Highly Drug-Resistant Escherichia coli from Hospital Wastewater with Several Evolutionary Mutations: An Integrated Insights from Molecular, Computational, and Biophysics.Mol Biotechnol. 2025 Mar 16. doi: 10.1007/s12033-025-01410-y. Online ahead of print. Mol Biotechnol. 2025. PMID: 40091143
-
Health professional and facility engagement in antimicrobial resistance prevention and containment strategic initiatives at public hospitals in Southern Ethiopia: facility-based cross-sectional study.BMJ Public Health. 2025 Apr 17;3(1):e002314. doi: 10.1136/bmjph-2024-002314. eCollection 2025. BMJ Public Health. 2025. PMID: 40260122 Free PMC article.
-
Comprehensive genomic analysis reveals virulence and antibiotic resistance genes in a multidrug-resistant Bacillus cereus isolated from hospital wastewater in Bangladesh.Sci Rep. 2025 Jul 2;15(1):22915. doi: 10.1038/s41598-025-06655-w. Sci Rep. 2025. PMID: 40594904 Free PMC article.
-
Drug resistant Klebsiella pneumoniae from patients and hospital effluent: a correlation?BMC Microbiol. 2025 May 11;25(1):284. doi: 10.1186/s12866-025-03987-5. BMC Microbiol. 2025. PMID: 40350461 Free PMC article.
References
-
- Sartorius B., Gray A.P., Weaver N.D., Aguilar G.R., Swetschinski L.R., Ikuta K.S., Mestrovic T., Chung E., Wool E.E., Han C. The burden of bacterial antimicrobial resistance in the WHO African region in 2019: A cross-country systematic analysis. Lancet Glob. Health. 2024;12:e201–e216. doi: 10.1016/S2214-109X(23)00539-9. - DOI - PMC - PubMed
-
- Joachim A., Manyahi J., Issa H., Lwoga J., Msafiri F., Majigo M. Predominance of Multidrug-Resistant Gram-Negative Bacteria on Contaminated Surfaces at a Tertiary Hospital in Tanzania: A Call to Strengthening Environmental Infection Prevention and Control Measures. Curr. Microbiol. 2023;80:148. doi: 10.1007/s00284-023-03254-8. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous